Brigham and Women's Hospital

The MATCH Study of HIV and Aging

  • Principal Investigator(s): Monty Montano
  • Study Contact: Brooke Ferguson Brawley; BBRAWLEY@PARTNERS.ORG617-525-9195
  • Description of Subjects: Adult males and females, 50-65 years old. If HIV+, on effective ART.
  • Location (Domestic vs. International): Boston Metropolitan Area
  • Enrollment Period: 2015-2016
  • Enrollment Goal: 200

Cotrimoxazole safety study

  • Principal Investigator(s): Scott Dryden-Peterson
  • Study Contact: Scott Dryden-Peterson, +2.677.447.2522, scott_peterson@post.harvard.edu
  • Description of Subjects: Infants born to HIV-infected women
  • Location (Domestic vs. International): Botswana
  • Enrollment Period: 2008-2009
  • Enrollment Goal: 444 mother-infant pairs

Botswana Prospective Cancer Cohort

  • Principal Investigator(s): Scott Dryden-Peterson
  • Study Contact: Scott Dryden-Peterson, +2.677.447.2522, scott_peterson@post.harvard.edu
  • Description of Subjects: Botswana adults with a new diagnosis of cancer
  • Location (Domestic vs. International): Botswana Harvard AIDS Institute
  • Enrollment Period: 2010-ongoing
  • Enrollment Goal: 3000

Effect on CNS with ART switch off EFV-based therapy

  • Principal Investigator(s): Nina LIn
  • Study Contact:  Nina Lin, Tel: 617-768-8479, nhlin@partners.org
  • Description of Subjects:  Effect on CNS with ART switch off EFV-based therapy
  • Location (Domestic vs. International): Domestic, BWH (recruiting can be from MGH or BIDMC)
  • Enrollment Period: Beginning January 2014

HIV and Aging Cohort Study

  • Principal Investigator(s): Nina Lin
  • Study Contact:  Nina Lin, Tel: 617-768-8479, nhlin@partners.org
  • Description of Subjects:  HIV+ on ART who are </= 35 yo or >/=50yo with no hepatitis co-infection
  • Location (Domestic vs. International): Domestic, BWH, BIDMC, MGH
  • Enrollment Period: 2011-present
  • Enrollment Goal: